BEIGENE (06160) intends to change its English name to "BeOne Medicines Ltd."

BEIGENE (06160) announced that for the purpose of continuity, the board of directors proposes to change the company's English name from "BeiGene, Ltd." to "BeOne Medicines Ltd." and adopt a proposed Swiss Articles of Association that includes the proposed company name change. The company's Chinese name will remain unchanged. The announcement stated that the new English name reflects the company's commitment to developing innovative drugs and working with stakeholders globally to serve more patients and eliminate cancer. The board believes that the proposed company name change is in the overall interest of the company and shareholders.